Effects of vitamin e on bone turnover markers among US postmenopausal women

Journal of Bone and Mineral Research

Volumn 27, Issue 6, 2012, Pages 1368-1380

  Hamidi, Maryam S ^a,b   Corey, Paul N ^c   Cheung, Angela M ^a,b,c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

AGING; ALPHA TOCOPHEROL; BONE TURNOVER MARKERS; GAMMA TOCOPHEROL; NUTRITION; OSTEOPOROSIS; VITAMIN E; WOMEN

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; ALPHA TOCOPHEROL; AMINO TERMINAL TELOPEPTIDE; CREATININE; GAMMA TOCOPHEROL;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE TURNOVER; CONTROLLED STUDY; CREATININE URINE LEVEL; CROSS-SECTIONAL STUDY; FEMALE; HEALTH CARE SURVEY; HUMAN; MULTIPLE REGRESSION; OSSIFICATION; OSTEOLYSIS; POSTMENOPAUSE; UNITED STATES; VITAMIN BLOOD LEVEL; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

AGED; AGED, 80 AND OVER; ALKALINE PHOSPHATASE; ALPHA-TOCOPHEROL; BIOLOGICAL MARKERS; BONE REMODELING; COLLAGEN TYPE I; DIETARY SUPPLEMENTS; FEMALE; GAMMA-TOCOPHEROL; HUMANS; MIDDLE AGED; PEPTIDES; POSTMENOPAUSE; UNITED STATES; VITAMIN E;

EID: 84859593877     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.1566     Document Type: Article

References (95)

1. National Osteoporosis Foundation. Fast Facts-Osteoporosis Prevalence: Gender. [Internet]. Washington, DC: National Osteoporosis Foundation [cited 2012 February 8]. Available from
2. Pfeilschifter J, Koditz R, Pfohl M, Schatz H., Changes in proinflammatory cytokine activity after menopause. Endocr Rev. 2002; 23 (1): 90-119.
3. Mundy GR., Osteoporosis and inflammation. Nutr Rev. 2007; 65 (12 Pt 2): S147-51.
4. Singh U, Devaraj S, Jialal I., Vitamin E, oxidative stress, and inflammation. Annu Rev Nutr. 2005; 25: 151-74.
5. Jiang Q, Christen S, Shigenaga MK, Ames BN., gamma-tocopherol, the major form of vitamin E in the US diet, deserves more attention. Am J Clin Nutr. 2001; 74 (6): 714-22.
6. Behrens WA, Madere R., Alpha- and gamma tocopherol concentrations in human serum. J Am Coll Nutr. 1986; 5 (1): 91-6.
7. The Office of Dietary Supplements (ODS). Dietary Supplement Fact Sheet: Vitamin E [Internet]. Bethesda, MD: Office of Dietary Supplements (ODS), National Institutes of Health, U.S. Department of Health and Human Services [cited 2012 February 8]. Available from
8. Gao X, Wilde PE, Lichtenstein AH, Bermudez OI, Tucker KL., The maximal amount of dietary alpha-tocopherol intake in U.S. adults (NHANES 2001-2002). J Nutr. 2006; 136 (4): 1021-6.
9. McLaughlin PJ, Weihrauch JL., Vitamin E content of foods. J Am Diet Assoc. 1979; 75 (6): 647-65.
10. Dietrich M, Traber MG, Jacques PF, Cross CE, Hu Y, Block G., Does gamma-tocopherol play a role in the primary prevention of heart disease and cancer?. A review. J Am Coll Nutr. 2006; 25 (4): 292-9.
11. Wagner KH, Kamal-Eldin A, Elmadfa I., Gamma-tocopherol-an underestimated vitamin?. Ann Nutr Metab. 2004; 48 (3): 169-88.
12. Mayne ST., Antioxidant nutrients and chronic disease: use of biomarkers of exposure and oxidative stress status in epidemiologic research. J Nutr. 2003; 133 (Suppl 3): 933S-40S.
13. Maras JE, Bermudez OI, Qiao N, Bakun PJ, Boody-Alter EL, Tucker KL., Intake of alpha-tocopherol is limited among US adults. J Am Diet Assoc. 2004; 104 (4): 567-75.
14. Arab L., Biomarkers of fat and fatty acid intake. J Nutr. 2003; 133 (Suppl 3): 925S-32S.
15. Prentice RL., Measurement error and results from analytic epidemiology: dietary fat and breast cancer. J Natl Cancer Inst. 1996; 88 (23): 1738-47.
16. Heitmann BL, Lissner L, Osler M., Do we eat less fat, or just report so?. Int J Obes Relat Metab Disord. 2000; 24 (4): 435-42.
17. Leonard SW, Good CK, Gugger ET, Traber MG., Vitamin E bioavailability from fortified breakfast cereal is greater than that from encapsulated supplements. Am J Clin Nutr. 2004; 79 (1): 86-92.
18. National Institutes of Health State-of-the-Science Panel. National Institutes of Health State-of-the-Science Conference Statement: multivitamin/mineral supplements and chronic disease prevention. Am J Clin Nutr. 2007; 85 (1): 257S-64S.
19. Dary O, Mora JO., Food fortification to reduce vitamin A deficiency: International Vitamin A Consultative Group recommendations. J Nutr. 2002; 132 (9 Suppl): 2927S-33S.
20. Ortiz-Andrellucchi A, Sanchez-Villegas A, Doreste-Alonso J, de Vries J, de Groot L, Serra-Majem L., Dietary assessment methods for micronutrient intake in elderly people: a systematic review. Br J Nutr. 2009; 102 (Suppl 1): S118-49.
21. Campbell S, Stone W, Whaley S, Krishnan K., Development of gamma (gamma)-tocopherol as a colorectal cancer chemopreventive agent. Crit Rev Oncol Hematol. 2003; 47 (3): 249-59.
22. Usoro OB, Mousa SA., Vitamin E forms in Alzheimer's disease: a review of controversial and clinical experiences. Crit Rev Food Sci Nutr. 2010; 50 (5): 414-9.
23. Kushi LH, Folsom AR, Prineas RJ, Mink PJ, Wu Y, Bostick RM., Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med. 1996; 334 (18): 1156-62.
24. Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Aggarwal N, Wilson RS, Scherr PA., Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA. 2002; 287 (24): 3230-7.
25. Morris MC, Evans DA, Tangney CC, Bienias JL, Wilson RS, Aggarwal NT, Scherr PA., Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change. Am J Clin Nutr. 2005; 81 (2): 508-14.
26. Miller ER 3rd, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E., Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005; 142 (1): 37-46.
27. Wolf RL, Cauley JA, Pettinger M, Jackson R, Lacroix A, Leboff MS, Lewis CE, Nevitt MC, Simon JA, Stone KL, Wactawski-Wende J., Lack of a relation between vitamin and mineral antioxidants and bone mineral density: results from the Women's Health Initiative. Am J Clin Nutr. 2005; 82 (3): 581-8.
28. Baker H, Handelman GJ, Short S, Machlin LJ, Bhagavan HN, Dratz EA, Frank O., Comparison of plasma alpha and gamma tocopherol levels following chronic oral administration of either all-rac-alpha-tocopheryl acetate or RRR-alpha-tocopheryl acetate in normal adult male subjects. Am J Clin Nutr. 1986; 43 (3): 382-7.
29. El-Sohemy A, Baylin A, Ascherio A, Kabagambe E, Spiegelman D, Campos H., Population-based study of alpha- and gamma-tocopherol in plasma and adipose tissue as biomarkers of intake in Costa Rican adults. Am J Clin Nutr. 2001; 74 (3): 356-63.
30. Eastell R, Hannon RA., Biomarkers of bone health and osteoporosis risk. Proc Nutr Soc. 2008; 67 (2): 157-62.
31. Seeman E., Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis. Osteoporos Int. 2003; 14 (Suppl 3): S2-8.
32. Melton LJ III, Khosla S, Atkinson EJ, O'Fallon WM, Riggs BL., Relationship of bone turnover to bone density and fractures. J Bone Miner Res. 1997; 12 (7): 1083-91.
33. Gundberg CM, Looker AC, Nieman SD, Calvo MS., Patterns of osteocalcin and bone specific alkaline phosphatase by age, gender, and race or ethnicity. Bone. 2002; 31 (6): 703-8.
34. Bollen AM, Kiyak HA, Eyre DR., Longitudinal evaluation of a bone resorption marker in elderly subjects. Osteoporos Int. 1997; 7 (6): 544-9.
35. Minisola S, Pacitti MT, Ombricolo E, Costa G, Scarda A, Palombo E, Rosso R., Bone turnover and its relationship with bone mineral density in pre- and postmenopausal women with or without fractures. Maturitas. 1998; 29 (3): 265-70.
36. Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS), National Health and Nutrition Examination Survey (NHANES) data years 1999-2000 and 2001-2002 [Internet]. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention [cited 2012 February 8]. Available from
37. Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS), National Health and Nutrition Examination Survey (NHANES) Response Rates [Internet]. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention [cited 2012 February 8]. Available from
38. Backer LC, Rubin CS, Marcus M, Kieszak SM, Schober SE., Serum follicle-stimulating hormone and luteinizing hormone levels in women aged 35-60 in the U.S. population: the Third National Health and Nutrition Examination Survey (NHANES III, 1988-1994). Menopause. 1999; 6 (1): 29-35.
39. Henrich JB, Hughes JP, Kaufman SC, Brody DJ, Curtin LR., Limitations of follicle-stimulating hormone in assessing menopause status: findings from the National Health and Nutrition Examination Survey (NHANES 1999-2000). Menopause. 2006; 13 (2): 171-7.
40. Gopal DV, Rosen HR., Abnormal findings on liver function tests. Interpreting results to narrow the diagnosis and establish a prognosis. Postgrad Med. 2000; 107 (2): 100-2, 105-9, 113-4.
41. Couchoud C, Pozet N, Labeeuw M, Pouteil-Noble C., Screening early renal failure: cut-off values for serum creatinine as an indicator of renal impairment. Kidney Int. 1999; 55 (5): 1878-84.
42. Blanton CA, Moshfegh AJ, Baer DJ, Kretsch MJ., The USDA Automated Multiple-Pass Method accurately estimates group total energy and nutrient intake. J Nutr. 2006; 136 (10): 2594-9.
43. Moshfegh AJ, Rhodes DG, Baer DJ, Murayi T, Clemens JC, Rumpler WV, Paul DR, Sebastian RS, Kuczynski KJ, Ingwersen LA, Staples RC, Cleveland LE., The US Department of Agriculture Automated Multiple-Pass Method reduces bias in the collection of energy intakes. Am J Clin Nutr. 2008; 88 (2): 324-32.
44. Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS), National Health and Nutrition Examination Survey (NHANES) Data Dietary Interview-Total Nutrients Intakes, and 30-Day Dietary Supplement Use 1999-2000 and 2001-2002 [Internet]. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention [cited 2012 February 8]. Available from
45. Friday J, Bowman S., 2006. USDA Database of Vitamin A (mcg RAE) and Vitamin E (mg AT) for National Health and Nutrition Examination Survey 1999-2000 [Internet]. Beltsville, MD: Food Surveys Research Group, Agricultural Research Service, U.S. Department of Agriculture [cited 2012 February 8]. Available from
46. Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS), National Health and Nutrition Examination Survey (NHANES) Data 1999-2002. Vitamin E- Data Documentation and Laboratory Procedure Manuals [Internet]. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention [cited 2012 February 8]. Available from
47. Traber MG., Vitamin E regulatory mechanisms. Annu Rev Nutr. 2007; 27: 347-62.
48. Gao R, Stone WL, Huang T, Papas AM, Qui M., The uptake of tocopherols by RAW 264.7 macrophages. Nutr J. 2002; 1: 2.
49. Huang HY, Appel LJ., Supplementation of diets with alpha-tocopherol reduces serum concentrations of gamma- and delta-tocopherol in humans. J Nutr. 2003; 133 (10): 3137-40.
50. Wolf G., How an increased intake of alpha-tocopherol can suppress the bioavailability of gamma-tocopherol. Nutr Rev. 2006; 64 (6): 295-9.
51. Ingles SA, Bird CL, Shikany JM, Frankl HD, Lee ER, Haile RW., Plasma tocopherol and prevalence of colorectal adenomas in a multiethnic population. Cancer Res. 1998; 58 (4): 661-6.
52. Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS), National Health and Nutrition Examination Survey (NHANES). BAP and uNTx/Cr Data Documentation and Laboratory Procedure Manuals 1999-2000 and 2001-2002 [Internet]. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention [cited 2012 February 8]. Available from
53. Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS), National Health and Nutrition Examination Survey (NHANES). Urinary Creatinine Laboratory Procedure Manuals 1999-2000 and 2001-2002 [Internet]. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention [cited 2012 February 8]. Available from
54. Benowitz NL, Bernert JT, Caraballo RS, Holiday DB, Wang J., Optimal serum cotinine levels for distinguishing cigarette smokers and nonsmokers within different racial/ethnic groups in the United States between 1999 and 2004. Am J Epidemiol. 2009; 169 (2): 236-48.
55. Willett WC, Howe GR, Kushi LH., Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr. 1997; 65 (4 Suppl): 1220S-8S; discussion 1229S-31S.
56. Ford ES, Schleicher RL, Mokdad AH, Ajani UA, Liu S., Distribution of serum concentrations of alpha-tocopherol and gamma-tocopherol in the US population. Am J Clin Nutr. 2006; 84 (2): 375-83.
57. Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS), National Health and Nutrition Examination Survey (NHANES). Serum Cholesterol Data Documentation and Laboratory Procedure Manuals 1999-2000 and 2001-2002 [Internet]. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention [cited 2012 February 8]. Available from
58. Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS), National Health and Nutrition Examination Survey (NHANES). Serum Triglyceride- Data Documentation and Laboratory Procedure Manuals 1999-2000 and 2001-2002 [Internet]. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention [cited 2012 February 8]. Available from
59. Keene ON., The log transformation is special. Stat Med. 1995; 14 (8): 811-9.
60. SAS Institute Inc. 2010 SAS® 9.2 Software [Internet]. Cary, NC: SAS Institute, Inc. [cited 2012 February 8]. Available from
61. Cooney RV, Franke AA, Harwood PJ, Hatch-Pigott V, Custer LJ, Mordan LJ., Gamma-tocopherol detoxification of nitrogen dioxide: superiority to alpha-tocopherol. Proc Natl Acad Sci U S A. 1993; 90 (5): 1771-5.
62. Wolf G., gamma-Tocopherol: an efficient protector of lipids against nitric oxide-initiated peroxidative damage. Nutr Rev. 1997; 55 (10): 376-8.
63. Jordan JM, De Roos AJ, Renner JB, Luta G, Cohen A, Craft N, Helmick CG, Hochberg MC, Arab L., A case-control study of serum tocopherol levels and the alpha- to gamma-tocopherol ratio in radiographic knee osteoarthritis: the Johnston County Osteoarthritis Project. Am J Epidemiol. 2004; 159 (10): 968-77.
64. Jamal SA, Hamilton CJ, Eastell R, Cummings SR., Effect of nitroglycerin ointment on bone density and strength in postmenopausal women: a randomized trial. JAMA. 2011; 305 (8): 800-7.
65. Khosla S., Is nitroglycerin a novel and inexpensive treatment for osteoporosis?. JAMA. 2011; 305 (8): 826-7.
66. van't Hof RJ, Ralston SH., Nitric oxide and bone. Immunology. 2001; 103 (3): 255-61.
67. Devaraj S, Leonard S, Traber MG, Jialal I., Gamma-tocopherol supplementation alone and in combination with alpha-tocopherol alters biomarkers of oxidative stress and inflammation in subjects with metabolic syndrome. Free Radic Biol Med. 2008; 44 (6): 1203-8.
68. Jiang Q, Ames BN., Gamma-tocopherol, but not alpha-tocopherol, decreases proinflammatory eicosanoids and inflammation damage in rats. FASEB J. 2003; 17 (8): 816-22.
69. Watkins BA, Li Y, Lippman HE, Seifert MF., Biochemical and molecular actions of fatty acids in bone modeling. World Rev Nutr Diet. 2001; 88: 126-40.
70. Manolagas SC, Jilka RL., Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med. 1995; 332 (5): 305-11.
71. Arjmandi B, Juma S, Beharka A, Bapna M, Akhter M, Meydani S., Vitamin E improves bone quality in the aged but not in young adult male mice. J Nutr Biochem. 2002; 13 (9): 543.
72. Shuid AN, Mehat Z, Mohamed N, Muhammad N, Soelaiman IN., Vitamin E exhibits bone anabolic actions in normal male rats. J Bone Miner Metab. 2010; 28 (2): 149-156.
73. Norazlina M, Ima-Nirwana S, Gapor MT, Khalid BA., Palm vitamin E is comparable to alpha-tocopherol in maintaining bone mineral density in ovariectomised female rats. Exp Clin Endocrinol Diabetes. 2000; 108 (4): 305-10.
74. Ahmad NS, Khalid BA, Luke DA, Ima Nirwana S., Tocotrienol offers better protection than tocopherol from free radical-induced damage of rat bone. Clin Exp Pharmacol Physiol. 2005; 32 (9): 761-70.
75. Mehat MZ, Shuid AN, Mohamed N, Muhammad N, Soelaiman IN., Beneficial effects of vitamin E isomer supplementation on static and dynamic bone histomorphometry parameters in normal male rats. J Bone Miner Metab. 2010; 28 (5): 503-9.
76. Hermizi H, Faizah O, Ima-Nirwana S, Ahmad Nazrun S, Norazlina M., Beneficial effects of tocotrienol and tocopherol on bone histomorphometric parameters in Sprague-Dawley male rats after nicotine cessation. Calcif Tissue Int. 2009; 84 (1): 65-74.
77. Smith BJ, Lucas EA, Turner RT, Evans GL, Lerner MR, Brackett DJ, Stoecker BJ, Arjmandi BH., Vitamin E provides protection for bone in mature hindlimb unloaded male rats. Calcif Tissue Int. 2005; 76 (4): 272-9.
78. Chai SC, Wei CI, Brummel-Smith K, Arjmandi BH., The role of vitamin E in reversing bone loss. Aging Clin Exp Res. 2008; 20 (6): 521-7.
79. Tafazoli S, Wright JS, O'Brien PJ., Prooxidant and antioxidant activity of vitamin E analogues and troglitazone. Chem Res Toxicol. 2005; 18 (10): 1567-74.
80. Soeta S, Higuchi M, Yoshimura I, Itoh R, Kimura N, Aamsaki H., Effects of vitamin E on the osteoblast differentiation. J Vet Med Sci. 2010; 72 (7): 951-7.
81. Stein GS, Lian JB., Molecular mechanisms mediating proliferation/ differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr Rev. 1993; 14 (4): 424-42.
82. Mayne ST, Wright ME, Cartmel B., Assessment of antioxidant nutrient intake and status for epidemiologic research. J Nutr. 2004; 134 (11): 3199S-200S.
83. Klein EA, Thompson IM Jr, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, Minasian LM, Ford LG, Parnes HL, Gaziano JM, Karp DD, Lieber MM, Walther PJ, Klotz L, Parsons JK, Chin JL, Darke AK, Lippman SM, Goodman GE, Meyskens FL Jr, Baker LH., Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2011; 306 (14): 1549-56.
84. Liu M, Wallmon A, Olsson-Mortlock C, Wallin R, Saldeen T., Mixed tocopherols inhibit platelet aggregation in humans: potential mechanisms. Am J Clin Nutr. 2003; 77 (3): 700-6.
85. Bostick RM, Potter JD, McKenzie DR, Sellers TA, Kushi LH, Steinmetz KA, Folsom AR., Reduced risk of colon cancer with high intake of vitamin E: the Iowa Women's Health Study. Cancer Res. 1993; 53 (18): 4230-7.
86. Booth SL, Suttie JW., Dietary intake and adequacy of vitamin K. J Nutr. 1998; 128 (5): 785-8.
87. Macdonald HM, McGuigan FE, Lanham-New SA, Fraser WD, Ralston SH, Reid DM., Vitamin K1 intake is associated with higher bone mineral density and reduced bone resorption in early postmenopausal Scottish women: no evidence of gene-nutrient interaction with apolipoprotein E polymorphisms. Am J Clin Nutr. 2008; 87 (5): 1513-20.
88. Salari P, Rezaie A, Larijani B, Abdollahi M., A systematic review of the impact of n-3 fatty acids in bone health and osteoporosis. Med Sci Monit. 2008; 14 (3): RA37-44.
89. Macdonald HM, New SA, Golden MH, Campbell MK, Reid DM., Nutritional associations with bone loss during the menopausal transition: evidence of a beneficial effect of calcium, alcohol, and fruit and vegetable nutrients and of a detrimental effect of fatty acids. Am J Clin Nutr. 2004; 79 (1): 155-65.
90. Greenspan SL, Dresner-Pollak R, Parker RA, London D, Ferguson L., Diurnal variation of bone mineral turnover in elderly men and women. Calcif Tissue Int. 1997; 60 (5): 419-23.
91. Clowes JA, Hannon RA, Yap TS, Hoyle NR, Blumsohn A, Eastell R., Effect of feeding on bone turnover markers and its impact on biological variability of measurements. Bone. 2002; 30 (6): 886-90.
92. Schlemmer A, Hassager C., Acute fasting diminishes the circadian rhythm of biochemical markers of bone resorption. Eur J Endocrinol. 1999; 140 (4): 332-7.
93. Perneger TV., What's wrong with Bonferroni adjustments. BMJ. 1999; 316 (7139): 1236-8.
94. Colditz GA., Overview of the epidemiology methods and applications: strengths and limitations of observational study designs. Crit Rev Food Sci Nutr. 2010; 50 (Suppl 1): 10-2.
95. Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD., Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. J Bone Miner Res. 2000; 15 (8): 1526-36.